Usami T, Koyama K, Takeuchi O, Morozumi K, Kimura G
Department of Internal Medicine and Pathophysiology, Nagoya City University Medical School, Mizuho-ku, Nagoya 467-8601 Japan.
JAMA. 2000;284(20):2622-4. doi: 10.1001/jama.284.20.2622.
Despite recent medical advances, the number of patients beginning dialysis annually is increasing in both the United States and Japan. The ethnically homogeneous population of Japan presents an opportunity to study the presence of factors other than race/ethnicity that might contribute to incidence of end-stage renal disease (ESRD).
To determine if and where regional differences exist in ESRD in Japan.
DESIGN, SETTING, AND SUBJECTS: Analysis of data reported by the Japanese Society for Dialysis Therapy based on the annual number of patients with ESRD beginning maintenance dialysis therapy in all 47 prefectures of Japan from 1982 to 1998.
Mean annual ESRD incidence and increasing rate of ESRD in each of 11 predefined areas making up the entire country.
Incidence of ESRD increased approximately 3-fold in Japan during the study years, from 81.3 per 1 million in 1982 to 237.6 per 1 million in 1998. Significant regional differences were found in both measures. The mean (SEM) annual ESRD incidence (P<.01) and increasing rate of ESRD (P<.01), respectively, were significantly different across Japan. Koshinetsu (140 [11] per 1 million and 9.1 [0.6] per 1 million/y) and Hokuriku (141 [12] per 1 million and 9.7 [0.5] per 1 million/y) were the areas with the lowest incidence and increasing rate of incidence, while Okinawa (188 [17] per 1 million and 13.4 [0.6] per 1 million/y) and Kyushu (179 [15] per 1 million and 12.0 [0.6] per 1 million/y) were the areas with the highest incidence and increasing rate of incidence.
We found definite and significant regional differences in incidence and increasing rate of incidence of ESRD in Japan. Further analyses are needed to identify factors that contribute to these regional differences and thereby improve strategies for treatment of renal disease. JAMA. 2000;284:2622-2624.
尽管近年来医学取得了进展,但美国和日本每年开始接受透析治疗的患者数量仍在增加。日本种族单一的人口为研究种族/民族以外可能导致终末期肾病(ESRD)发病率的因素提供了机会。
确定日本ESRD是否存在地区差异以及差异所在。
设计、地点和研究对象:对日本透析治疗学会报告的数据进行分析,这些数据基于1982年至1998年日本47个都道府县中开始接受维持性透析治疗的ESRD患者的年度数量。
构成整个国家的11个预定义区域中每个区域的ESRD年平均发病率和ESRD发病率的增长率。
在研究期间,日本ESRD的发病率增加了约3倍,从1982年的每100万人中81.3例增加到1998年的每100万人中237.6例。在这两项指标上均发现了显著的地区差异。日本各地的ESRD年平均发病率(P<0.01)和ESRD发病率的增长率(P<0.01)存在显著差异。甲信越地区(每100万人中140[11]例,每年每100万人中9.1[0.6]例)和北陆地区(每100万人中141[12]例,每年每100万人中9.7[0.5]例)是发病率和发病率增长率最低的地区,而冲绳地区(每100万人中188[17]例,每年每100万人中13.4[0.6]例)和九州地区(每100万人中179[15]例,每年每100万人中12.0[0.6]例)是发病率和发病率增长率最高的地区。
我们发现日本ESRD的发病率和发病率增长率存在明确且显著的地区差异。需要进一步分析以确定导致这些地区差异的因素,从而改进肾病治疗策略。《美国医学会杂志》。2000年;284:2622 - 2624。